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Molecular dynamics simulationTWIK (tandem-pore domain weak inward rectifying K+)-related spinal cord K+ channel, TRESK, a member of
the tandem-pore domain K+ channel family, is the most recently cloned K2P channel. TRESK is highly
expressed in dorsal root ganglion neuron, a pain sensing neuron, which is a target for analgesics. In this
study, a reliable 3D structure for transmembrane (TM) region of mouse TRESK (mTRESK) was constructed,
and then the reasonable blocker binding mode of the protein was investigated. The 3D structure of the
mTRESK built by homology modeling method was validated with recommend value of stereochemical qual-
ity. Based on the validated structure, K+ channel blocker-bound conformation was obtained by molecular
docking and 5 ns MD simulation with DPPC lipid bilayer. Our docking study provides the plausible binding
mode of known blockers with key interacting residues, especially, F156 and F364. Finally, these modeling
results were veriﬁed by experimental study with mutation from phenylalanine to alanine (F156A, F364A
and F156A/F364A) at the TM2 and TM4. This is the ﬁrst modeling study for TRESK that can provide structural
information of the protein including ligand binding information. These results can be useful in structure
based drug design for ﬁnding new blockers of the TRESK as potential therapeutic target of pain treatment.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Potassium channels (K+ channels) play important roles in the regu-
lation of cell growth, cell excitability, cell volume, and proliferation, as
well as cell death. All K+ channels share a common functional feature
with respect to selectivity for K+ ions. It is associated with a conserved
TVGYG motif which is important for selectivity ﬁlter of the pore-
forming region (P-domain or P-loop) of the channel proteins [1–4].
The K+ channels are characterized by the number of transmembrane
(TM) domains (two, four, or six) and P-loops (one or two) [5].
The two-pore-domain K+ (K2P) channels contribute to the back-
ground (or leak) K+ currents, which are responsible for the resting
membrane potential and excitability of several excitable and
nonexcitable cell types in mammalian [6,7]. In heterologous systems,
K2P channels could act as putative targets for various factors, includingand Institute of Health Sciences,
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and it can be divided into six subfamilies based on amino acid homol-
ogy, and their structural and functional properties: TWIK (TWIK-1,
TWIK-2, and KCNK7), TREK (TREK-1, TREK-2, and TRAAK), TASK
(TASK-1, TASK-3, and TASK-5), TALK (TALK-1, TALK-2, and TASK-2),
THIK (THIK-1 and THIK-2), and TRESK [1,8–21]. The channels play a
key role in cellular mechanisms of neuroprotection, anesthesia, pain,
and depression. In addition, they are modulated by cellular lipids, phar-
macological agents, polyunsaturated fatty acids, and volatile general an-
esthetics [16]. Each subunit of K2P channels consists of four TMdomains
(TM1-TM4) and two P-loops, and two subunits assemble to form a
functional dimeric K+ channel. Moreover, the channels possess an evo-
lutionarily conserved extended extracellular loop between TM1 and P1
(TM1-P1 loop), and the P-loop of K2P channels contains a consensus
sequence motif of TxG(Y/F)G [7,11,16,18,22,23].
TWIK (tandem-pore domain weak inward rectifying K+)-related
spinal cord K+ channel (TRESK), a member of the tandem-pore domain
K+ channel family, is the most recently cloned K2P channel. Its mRNA
was expressed in a speciﬁc region of the human spinal cord and
mouse cerebellum, cerebrum, spleen, thymus as well as testis, cerebral
cortex, and especially dorsal root ganglion (DRG) [8,21,24,25]. Hy-
drophobicity analysis of the amino acid sequence for mouse TRESK
(mTRESK) channel revealed that the channel has two P-loops, four
TM domains, and one N-glycosylation sites in the TM1-P1 linker
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TRESK consists of extended intracellular loop between TM2 and
TM3 and a short C-terminal and N-terminal regions which located
on the intracellular side [21].
The TRESK is modulated by various intracellular and extracellular
factors such as arachidonic acid, Zn2+, volatile anesthetics, and GPCR
agonists [8,26–29]. This channel is uniquely regulated by the calcium
signal compared to the other K2P channels [24]. Because mTRESK
include an NFAT (nuclear factor of activated T-cells)-like consensus
motif for calcineurin binding such as PQIVID in mouse (PQIIIS in
human) at its intracellular loop between TM2 and TM3 (TM2-TM3
loop), it is activated in response to the calcium signal through binding
calcineurin, a calcium/calmodulin-dependent protein phosphatase [30].
Therefore, Cyclosporine A and FK506, immunosuppressive compounds,
which are calcineurin inhibitors widely used as immunosuppressors in
the clinic, prevent TRESK activation. The activation of TRESK could in-
duce activation of the transcription of new genes as well as regulation
of several aspects of T-cell function, therefore the channel is considered
as a potential target to treat T-cell mediated immune dysfunction
[24,30,31].
Several studies reported K2P homology modeled structure such as
TASK-1, TASK-2 and TALK-2, and TREK-1 and TREK-2 [17,32–35]. The
TRESK is highly expressed in dorsal root ganglion neuron, a pain
sensing neuron, which is a target for analgesics. However, little is
known about the 3D structure and drug binding site of TRESK
compared with other K2P channels. Therefore, the main objectives of
this study are to construct 3D structure of mTRESK and to predict
K+ channel blocker binding site. In this study, reasonable modeled
structures of mTRESK were generated using homology modeling
method. A suitable binding mode of known K+ channel blockers
into mTRESK structure was predicted, and key interacting residues
in blocker binding site were suggested in our molecular docking
study. In order to verify our modeling study, three TRESK mutants
(F156A, F364A, and F156A/F364A) were constructed. The TRESK cur-
rents were measured using whole-cell recording, a technique that
measures the movement of ions across the cell membrane. Pharmaco-
logical agents were tested at the cellular levels. Our modeling results
provide the structural insight into blocker binding site of TRESK, this
will be help to design structure-based drugs for TRESK as a potential
therapeutic target in pain treatment.
2. Materials and methods
2.1. Prediction of transmembrane helices
ThemTRESK sequence including 394 amino acidswas obtained from
UniProt (http://www.uniprot.org) (UniProt ID: Q6VV64). TMHMMv2.0
which is available at CBS (Center for Biological Sequence analysis,
http://www.cbs.dtu.dk/services/TMHMM) was used to predict trans-
membrane helices (TMHs) of mTRESK. The program is a method for
prediction of TMHs based on a hidden Markov model [36].
2.2. Generation of 3D structure
Sequence database search was carried out with blastp and PSI-BLAST
tools in NCBI (www.ncbi.nlm.nih.gov) to identify the homologue of
known structure from the PDB for template proteins of mTRESK. The
coordinates of MthK channel (PDB ID: 3LDC, 1.45 Å resolution) were
selected as a template to build the initial mTRESK structure. Sequence
alignment between mTRESK and template was performed by ClustalW2
program (http://www.ebi.ac.uk/Tools/clustalw2/index.html) [37]. Based
on the alignment, the 3D structure of mTRESK was constructed using
Build homology model protocol within Discovery studio 2.5 (DS2.5)
(Accelrys Inc., San Diego, USA). Two models were separately generated
depending on the extended TM1-P1 loop: Model 1 without loop, Model
2 with edited helices in loop region. The build and edit protein tool wasapplied to predict secondary structure as right-hand alpha helix for the
extended loop, the range of these helices was calculated by Predict
command in Secondary Structure from Sequence menu in DS2.5. The
orientation coordinates for monomer and homodimer of mTRESK struc-
ture were obtained by superimposition of the constructed homology
models with KcsA K+ channel structure (PDB ID: 1J95).
2.3. Solvated energy minimization and validation of 3D structure
Solvated energy minimization (EM) was carried out using the
GROMACS program (version 4.5.1) [38,39] with GROMOS96 53a6
force ﬁeld to reﬁne the homology modeled structure. The initial struc-
tures were inserted to an orthorhombic water box (1 nm thickness),
and the systemwas neutralized with the addition of 14 K+ counterions
by replacing water molecules. Long range electrostatics were handled
using the PME (particle mesh Ewald) method [40]. In a system, protein
alone consists of 4892 atoms and the entire system is made up of
101228 atoms in 32112 water molecules. To remove the possible bad
contacts from the initial structures, the steepest descent EM algorithm
was applied until energy convergence at 2000 kJ mol−1 nm−1.
The energy minimized structures were validated by three programs
such as PROCHECK, ProSA-web (https://prosa.services.came.sbg.ac.at/
prosa.php), and ERRAT version 2.0 (http://nihserver.mbi.ucla.edu/
ERRATv2/). The PROCHECK program was implemented to check the
stereochemical quality of protein structures with Ramachandran plot
[41]. The ProSA and ERRAT were also executed to evaluate the
constructed structures. The ProSA is an established tool which is
frequently employed in the reﬁnement and validation of experimental
protein structures, structure prediction, and modeling [42]. ERRAT is a
protein structure veriﬁcation algorithm that is especially well-suited
for evaluating the progress of crystallographic model building and
reﬁnement [43].
2.4. Pore radius analysis
The HOLE program (http://hole.biop.ox.ac.uk/hole) [44,45] was
utilized for analysis and visualization of the pore dimensions in homol-
ogy modeled mTRESK structure. The VMD program [46] was used to
visualize and to compare the pore surfaces between the template and
mTRESK.
2.5. Molecular dynamics simulation in explicit membrane environment
The minimized mTRESK model was oriented perpendicularly to
the membrane plane by Add Membrane and Orient Molecule Tool in
DS2.5 and then it was subjected to the molecular dynamics (MD) sim-
ulation with explicit membrane [47–50]. The coordinate and topology
of the DPPC containing 128 lipids for GROMACS were obtained from
the Web site of D. Peter Tieleman (http://moose.bio.ucalgary.ca).
The proper membrane system of 512 DPPCs was constructed based
on the extension of 128 DPPCs. The GROMOS 53a6 force ﬁeld [51]
was applied with added lipid parameters developed by Berger et al.
[52]. Initial structure was embedded in DPPC bilayer and solvated
with SPC (simple point charge) water model [53]. The coordinate
and topology of GROMACS for propafenone which shown the highest
ﬁtness score in pre-docking study were derived from PRODRG server
[54] The systems were neutralized by the addition of 14 K+ counter-
ions. The protein alone consists of 4448 atoms and the entire system
is made up of 129,303 atoms containing 33,135 water molecules and
508 DPPC molecules by removed 4 lipids from upper leaﬂet when
inserting protein into the lipid bilayer (252 lipids in the upper, 256
lipids in the lower leaﬂet). The steepest descent energy minimization
was calculated to remove possible bad contacts from the initial struc-
ture until energy convergence reached 1000 kJ/(mol∙nm). The
simulation was performed in the NVT ensemble during 100 ps to
stabilize the temperature of the system at 323 K. Continuously,
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system was subjected to normal pressure constant (1 bar) for 1 ns
under the conditions of position restraints for heavy atoms and
LINCS [55] constraints for all bonds. Production run was carried out
until 5 ns under periodic boundary conditions. Long range electro-
statics interactions were calculated by the PME method. Cutoff
distances for the calculation of the short-range electrostatic and van
der Waals interaction were 1.2 nm. The time step of the simulation
was set to 2 fs, and the coordinates were saved for analysis
every 2 ps. All analyses of MD simulations were carried out using
GROMACS package.
2.6. Molecular docking study
Molecular docking simulation was carried out to predict the bind-
ing modes of the blockers into the cavity of the mTRESK structure
using GOLD 4.1 program [56]. The program uses genetic algorithm
(GA) for docking of ﬂexible ligands into protein binding sites. In this
study, the GA parameters were set as default values. The reasonable
internal binding site of mTRESK structure for K+ channel blockers
was identiﬁed by Find Sites from Receptor Cavities method in Deﬁne
and Edit Binding site tools of DS2.5. The blockers such as propafenone,
quinine, lidocaine, and triethanolamine obtained from ChEMBL
(https://www.ebi.ac.uk/chembldb) were used for the docking simu-
lation. A radius was taken as 10 Å around the center of binding site in
mTRESK. The ﬂip and rotate options were applied for protonated
carboxylic acids, ring-NHR, and ring NR1R1 during the docking
simulation. The best docked poses of compounds were selected
based on the GoldScore ranking. The GOLD ﬁtness score calculated
by factors including H-bonding energy, van der Waals energy, and
ligand torsion strain has been optimized for the prediction of ligand
binding positions.
2.7. Transfection
Mouse TRESK (mTRESK, GenBank accession number NM_207261)
was a kind gift from Dr. Donghee Kim. The coding region of TRESK was
subcloned into pcDNA3.1/V5-His-TOPO vector (Invitrogen, Carlsbad,
CA, USA). HEK-293A cells were seeded at a density of 2×105 cells per
35-mm dish 24 h prior to transfection in Dulbecco's modiﬁed Eagle's
medium (DMEM) which included 10% fetal bovine serum (FBS;
Invitrogen, Grand Island, NY, USA). HEK-293A cells were co-transfected
with an mTRESK DNA in pcDNA3.1 and green ﬂuorescent protein (GFP)
in pcDNA3.1 using LipofectAMINE and Opti-MEM I Reduced Serum
Medium (Invitrogen). The cells expressing GFP were detected with a
microscope (Axiovert 135; Carl Zeiss Jena GmbH, Jena, Germany)
equipped with a mercury lamp light source. Cells were used 1–3 days
after transfection.
2.8. Site-directed mutagenesis
Single and double point mutations in mTRESK cDNAwere done using
a QuikChange site-directed mutagenesis kit (Stratagene, Santa Clara, CA,
USA) to generate penylalanin-to-alanine mutations according to the
instructions of the manufacturer (F156A, F364A, and F156A/F364A).
Both strands of mutated TRESK DNA fragments were sequenced for
conﬁrmation.
2.9. Electrophysiological studies
Electrophysiological recording was performed using a patch clamp
ampliﬁer (Axopatch 200, Axon Instruments, Union City, CA). Whole-cell
currentswere analyzedwith the pCLAMPprogram(Version 8). Bath solu-
tion for whole-cell recording contained (mM): 135 NaCl, 5 KCl, 1 CaCl2, 1
MgCl2, 5 glucose and 10 HEPES, and pipette solutions contained (mM):150 KCl, 1 MgCl2, 5 EGTA and 10 HEPES (pH 7.3). All other chemicals
were purchased from Sigma Chemical Co. (St Louis, MO, USA).
2.10. Statistical analysis
Data were analyzed using one-way ANOVA with Tukey's test used
for post hoc comparisons. All analyses were performed using SPSS
(version18, Chicago, IL, USA) and represented as the mean±SD.
Differences were considered signiﬁcant at pb0.05.
3. Results and discussion
3.1. Prediction of number and topology for transmembrane helices
The number of transmembrane helices (TMHs) and transmembrane
topology for mTRESK were predicted by TMHMM v2.0 server using a
hidden Markov model. The results showed that TRESK has six TMHs
consisting of each three TMH at N-terminal and C-terminal, respective-
ly. The second and ﬁfth TMHs were identiﬁed as P-loop domains which
are including conserved P-loop sequences (TxGxG). The long extended
loops such as TM1-P1 and TM2-TM3 loops were observed in the plot
showing posterior probabilities of inside/outside/TM helix (Fig. S1).
According to KangD et al., mTRESK has four TMHs, two P-loop domains,
extracellular TM1-P1 loop, and the extended intracellular TM2-TM3
loop [21]. The mTRESK topology obtained from TMHMM was used to
generate 3D structure of mTRESK.
3.2. Sequence alignment for the homology modeling
Sequence alignments of several reported K+ channel structures
(PDB ID: 2AHZ for NaK channel, 1XL4 for KirBac3.1 channel, 3LDC
for MthK, and 1J95 for KcsA) were performed for selecting the proper
template structure. Since MthK channel (PDB ID: 3LDC), which is in
open state rather than the closed state, was well aligned with
mTRESK, the structure was used as template. All K+ channels have a
highly conserved TVGYG motif (P-loop sequence) which is respon-
sible for selectivity ﬁlter. Since one subunit of mTRESK contains
two P-loops (P1-loop and P2-1oop) unlike other K+ channels,
TM1-P1-TM2 and TM3-P2-TM4 regions of mTRESK were separately
aligned with MthK channel (Fig. 1). The aligned sequence in P1
helix region was edited by removing gap region (ESWTVS—LYW→
ESWTVSLYW) which makes collapse in the secondary structure of
the P1 helix. The sequence alignment result for TM1-P1-TM2 region
showed 13.7% identity and 29.4% similarity with the template
(Fig. 1A). When considering only TM region of TM1-P1-TM2 without
TM1-P1 linker, sequence identity and similarity were slightly in-
creased to 29.4% and 53.6%, respectively. This is due to structural
property of K2P family; they possess extended extracellular TM1-P1
loop region. Although relatively low identity of TM1-P1-TM2 region
was observed, P1-loop of the region was perfectly aligned. In case of
TM3-P2-TM4, sequence identity and similarity was 27.0% and 52.8%,
respectively (Fig. 1B). From these sequence alignment results, the
sequences of the both TM1-P1-TM2 and TM3-P2-TM4 regions in
mTRESK were found to be similar with that of the template. The
P-loops were also found to be conserved well in mTRESK with the
template. Thus, the alignment was used to generate 3D structure of
mTRESK.
3.3. Generation of 3D structures using MthK as a template
Based on the TMHMM and sequence alignment results, the 3D
structures of TM regions for mTRESK were generated using homology
modeling method (Fig. 2). The structure consists of six TMHs
containing TM1-TM4, P1, and P2 helices (Fig. 1A). Two different
models were separately constructed and named as Model1 and
Model2 depending on type of the TM1-P1 loop. The Model1 suggests
Fig. 1. Sequence alignment of mTRESK with MthK (PDB ID: 3LDC). Sequence alignment results for the region of TM1-P1-TM2 (A) and TM3-P2-TM4 (B). Sequence identities are
indicated by asterisks (*), conservative substitutions by colons (:), and semi-conservative substitutions by dots (.). Extended extracellular loop region is denoted by green box
and predicted helix of Model2 is highlighted by orange color in the box. Each double-arrowhead lines represent TMH and P-loop (red) regions. TM topology sequences of mTRESK
reported by Kang D et al. are shown in bold and underlined. Key residues highlighted in blue box are considered for mutation study. The gray arrow indicates the glycine residue
which conserved in other K+ channels as a hinge residue.
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represents not only TM regions but also the extended loop including
two helices which are predicted by Secondary Structure Prediction
and constructed by Build and Edit Protein tools (Fig. 2B).
To obtain monomer and homodimer (dimer and tetramer, in case
of MthK) formation of mTRESK, crystal structure of KcsA (PDB ID:
1J95) which consists of tetramer was used to form functional channel
for two models (Fig. 2C, D, and E). In order to reﬁne the homology
modeled structures, calculation of solvated energy minimization
was carried out and then the ﬁnal structures were achieved.
After our modeling study was completed, the X-ray crystal struc-
tures of the K2P channels, TWIK-1 and TRAAK, were currently solved
[60,61]. The structures reveal the presence of a novel extracellular
helical cap domain that creates a bifurcated pore entryway. Although
we could not predict disulﬁde bond that covalently links the two
subunits, prediction of a part of two helices of the Model2 is corre-
sponding with the crystal structure (Fig. S4A). Since the main aim of
this study was to ﬁnd out the blocker binding site rather than to con-
struct the extracellular region, the results of this modeling study will
be continuously used for further study.
3.4. Validation for the structural quality
The PROCHECK, ProSA-Web, and ERRAT programs were performed
to validate the reﬁned model structures, and these results are detailed
in Table 1. The PROCHECK, a well-known protein structure checking
program was carried out to check stereochemical quality of homology
modeled structures and MthK structure (Fig. S2). Ramachandran plot
obtained from the PROCHECK showed that the 98.6% residues of MthK
structure and more than 90% residues of modeled 3D structures were
lied in the most favored regions: 97.2% for Model1 and 93.2% for
Model2 (Fig. S2A and B). Especially, the higher stereochemical quality
score was observed in the Model1 compared to that of the Model2.
There was no residue in disallowed region of Model1 structure and
only two residues in Model2 (Table 1). These results indicated thatour models are reasonable because the spot distributions were similar
to the template structure. Moreover, overall Goodness factor (G-factor)
indicating the quality of covalent and overall bond-angle distances was
0.12 for Model1, 0.03 for Model2. The G-factor is a measure of the over-
all ‘normality’ of the structurewhich provided from an average of all the
different G-factors of each residue in the structure [57]. Generally, the
G-factor should be above -0.5 for a dependable structure. It means our
structures are acceptable.
The z-score of twomodels was calculated using ProSA-web to check
overall model quality. The proper z-score values (within −2.6) were
observed in the twomodeled structures comparedwith that of the tem-
plate (−1.65). As the result, our structures are within the range of
scores typically found for native proteins of similar size which are
experimentally determined protein chains in current PDB [42].
ERRAT is protein structure veriﬁcation algorithm for non-bonded
atomic interactions between different atom types. The recommended
value of ERRAT is greater than 50 for higher quality model, and the
higher scores indicate the better quality [43]. In the case of our
models, each ERRAT value was 66.88, and 76.78 for Model1 and
Model2, respectively. Although low values of two models were
observed when compared with that of the template which is 100,
the models were found within the range of a high quality model. All
the validation results revealed that our models were successfully
constructed.
3.5. Structural comparison of pore region with template
AModel1was used to compare pore regionwith template (Fig. 3). In
order to compare pore region of Model1 with that of template, the two
structures were superimposed as shown in the Fig. 3A. Each RMSD
value for TM1-P1-TM2 region (Fig. 3A) and TM3-P2-TM4 region
(Fig. 3C) was calculated as 0.26 and 0.28 Å, respectively. Moreover,
the P-loops of the homology modeled structure were completely iden-
tical, and it showed that our model can form properly pore which is
responsible for K+ ion permeation (Fig. 3B and D).
Fig. 2. Homology modeling structures of mTRESK with and without loop region. Structure of mTRESK monomer without TM1-P1 loop region (Model1) (A) and with extended loop
including two predicted helices with extended ﬂexible loop (Model2) (B). Potassium ions are represented as magenta sphere. The Model1 is superimposed with MthK (PDB ID:
3LDC, gray). Each part of TM1-P1-TM2 and TM3-P2-TM4 is colored by orange and yellow, respectively. N-Glycosylation site (Asn83) is represented by stick model. Homodimeric
structure of Model1 followed by orientation of KcsA (PDB ID: 1J95) structure (C). Top view (D) and bottom view (E) of panel (C) clearly show the orientation.
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carried out using HOLE program. The different gate region between
mTRESK and MthK channels was observed through the analysis. The
narrow pore radius (within 0.5–1.0 Å) of selectivity ﬁlter was
detected in the both structures and the values are almost similar
(Fig. 4). However, in the case of the gate region, the narrower pore ra-
dius was investigated in mTRESK structure compared to the template
(Fig. 4B and C). The radius of gate region in the MthK was approxi-
mately 4Å, but that of the mTRESK structure was displayed as 2 Å
(Fig. 4C). Although the both structures are in open state, around
two fold differences were observed in the size of pore radius of gate
regions. This reason is considered that the mTRESK structure has
four phenylalanine residues, F156 of TM2 and F364 of TM4 in each
monomer, around gate region (Fig. 4B). This result suggests that
these residues can be form a narrow pore surrounding with volume
of the residues through the assembly of dimer.Table 1
Results of structure validation generated by PROCHECK, ProSA-web, and ERRAT tools.
Core (%) Allowed General Disallowed
MthK 98.6 1.4 0.0 0.0
Model 1 97.2 2.8 0.0 0.0
Model 2 93.2 5.8 0.0 1.1
a Overall G-factor score should be above −0.5 for a reliable model.
b ERRAT score should be above 50 for a reliable model.In order to compare pore regions between TRAAK and the mTRESK,
we performed additional pore radius analysis for the TRAAK, it showed
that the regionwasmorewider thanmTRSEK. The gate region in TRAAK
has different amino acids such as glycine (TM2) and alanine (TM4)
(Fig. S4).
3.6. Selection of representative structure for molecular docking
Generally, blockers of K+ channel can be bound on either side of the
membrane at each binding site (external or internal) [58]. In this study,
in order to ﬁnd out blocker binding site from the overall structure of
mTRESK, we selected internal site which was identiﬁed by Deﬁne and
Edit Binding site Tools in DS2.5. Sano Y et al. revealed that human
TRESK (hTRESK) was inhibited by K+ channel blockers such as
propafenone, glyburide (ATP-sensitive K+ channel blocker), lidocaine
(Na+ channel blocker), quinine, quinindine, and triethanolamineOverall G-factora Z-score (P1/P2) ERRATb score
0.41 −0.65 – 100
0.12 −2.55 −2.48 66.88
0.03 −2.59 −2.55 76.78
Fig. 3. Comparison of P-loops between mTRESK and MthK structures. The selectivity ﬁlter region showing with TVGYG motif of P1-loops (A) and TIGFG motif of P2-loops (C).
Superimposition of P1-loops (B) and P2-loops (D) between mTRESK and MthK. The motif residue and K+ ion are represented as a stick model and a magenta sphere, respectively.
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speciﬁc blocker for the mTRESK, these reported blocker compounds in-
cluding propafenone, quinine, lidocaine, and triethanolamine were se-
lected as blockers of mTRESK (Fig. 5).Fig. 4. Pore-lining surface and pore radius proﬁles. (A) Comparative illustrations of pore size
gray box) presented in mTRESK is shown in right panel. (B) Graph of pore radius proﬁles to c
red (pore radiusb1.15 Å), green (1.15 Åbpore radiusb2.3 Å), and blue (pore radius>2.3 ÅTo investigate the bindingmode of the blockers into the binding site,
molecular dockingwas used and thenMD simulationwas carried out to
reﬁne blocker bounded structure in a dipalmitoylphosphatidylcholine
(DPPC) bilayer (Fig. 6). Firstly, four blockers were docked into theof MthK (gray) and mTRESK (orange). Detailed view of cavity and gate (highlighted by
ompare between MthK and mTRESK. The pore radii are represented as different colors:
).
Fig. 5. Chemical structures of K+ channel blockers for molecular docking simulation.
1137S. Kim et al. / Biochimica et Biophysica Acta 1828 (2013) 1131–1142internal binding site of the protein structure to obtain the initial blocker
bound structure. All of the blockers were well docked into internal
binding site, and the conformations were placed in same position and
bindingmode. Since the propafenone of blockers has shown the highest
ﬁtness score compared to the others, propafenone bound complex was
used to MD simulation.
Before the MD simulation, the implicit membrane was added to
mTRESK structure using Add Membrane and Orient Molecule protocolFig. 6. Final conformations of Model1 (A) and Model2 (B) with the implicit membrane. Rep
layer and docked propafenone (represented by magenta stick model). The RMSD of the Cαto better understand the topology of the membrane as well as to
gain orientation of the structure in membrane environment (Fig. 6A
and B). The 5 ns MD simulation of the propafenone bounded mTRESK
model embedded in a lipid bilayer (Fig. 6C) was performed to acquire
adjusted protein conformation by propafenone as well as to reﬁne
homology model in explicit membrane environment. The backbone
root mean square deviation (RMSD) achieves stability after approxi-
mately 2500 ps and its average value was 0.42 nm during simulation
time. In addition stability of propafenone also adjusted after about
1500 ps and maintained 0.2 nm until the end of the simulation
(Fig. 6D). Based on these RMSD analyses, representative structures
(4570 ps frame) as ligand bound form was selected from the last
2 ns snapshots. Reﬁned representative structure was utilized to
molecular docking study.
3.7. Prediction of blocker binding site
Molecular docking studywas carried out to ﬁnd out suitable blocker
binding site using reﬁned representative structure (Fig. S3). As previous
docking simulation, four blockers such as propafenone, quinine, lido-
caine, and triethanolamine were docked to representative structure of
mTRESK (Fig. S3A) and all of blockers showed similar binding mode
to internal binding site of the mTRESK (Fig. S3B). The highest ﬁtness
score (64.77) was obtained in the case of propafenone, and the
respective score of the other compounds, quinine, lidocaine, and
triethanolamine was 53.90, 46.78, and 30.56, respectively. Among the
blockers, especially the triethanolamine showed the lowest ﬁtness
score (30.56). The reported experimental study from Sano Y et al. also
showed that triethanolamine (2 mM) blocked TRESK by 34%, whereas
propafenone (0.05 mM), quinine (0.1 mM), and lidocaine (1 mM)resentative structure of Model2 obtained from 5 ns MD simulation with DPPC lipid bi-
atom for mTRESK structure (D). The inset shows the RMSD calculated for propafenone.
Fig. 7. Prediction of blocker binding site of mTRESK. Binding modes of propafenone (A), quinine (B), lidocaine (C), and Triethanolamine (D). The π–π interactions are represented as
red lines and interacting key residues as stick models.
1138 S. Kim et al. / Biochimica et Biophysica Acta 1828 (2013) 1131–1142inhibited TRESK by more than 70% [1,8]. The reported experimental
results were found to be in accordance with our docking results show-
ing the effect of pi (π) interactions in ligand binding. In the docking
results, three blockers except for triethanolamine were participated in
the π interactions with hydrophobic residues of mTRESK (Fig. 7).
Several key interacting residues for the docked blockers were detected,
and its residues are listed in Table 2. Almost interacting residues in each
complex were located in TM2 (I152, F156, L157, L159, T160, and D161)
and TM4 (F364, I365, F367, K368, and L369). In addition, T335 belongs
to P2-loop was detected as hydrophobic interacting residue with lido-
caine and triethanolamine.
Especially, all blockers but triethanolamine contain aromatic ring
groups (Fig. 5), the blockers (propafenone, quinine, and lidocaine)
have formed π–π stacking interactionwith two phenylalanine residues,
F364 and F367 which are located in TM4 of mTRESK (Fig. 7A, B and C).
According to hERG K+ channel study by Masetti M et al. [59], aromatic
residues including tyrosine and phenylalanine were formed cation–π
and π–π stacking interaction with K+ channel blockers. Our docking
results also showed similar the π–π stacking interactions which were
observed between the aromatic ring groups of the blockers and theTable 2
Key interacting residues in blocker binding obtained from ﬁnal docked conformations.




















Triethanolamine Ile152(B), Phe156(A,B), Leu157(B),
Thr334(A), Thr335(A), Lys368(A)
Phe364 (A) _two phenylalanine residues. Particularly, the quinine has more π–π
stacking interaction compared with others due to the presence of
quinoline group (Fig. 7B). Whereas, the triethanolamine docking result
revealed that the F364 residue of mTRESK structure was formed only
one hydrogen bond with H atom of hydroxyl group in triethanolamine
(Fig. 7D). Therefore, π interaction seems to be strong effect on blocker
binding in mTRESK.
Interestingly, when we compared this docking result with previ-
ous pore radius analysis, we found that the key interacting residues
F156 and F364 were also involved into the formation of narrow cavity
in gate region. It can be concluded that the phenylalanine residues are
critical key residues for both binding of the blockers and forming the
narrow gate region. From our molecular docking simulation, we can
understand not only plausible binding mode of known K+ channel
blockers into the mTRESK but also signiﬁcant key residues of mTRESK.
3.8. Modulation of mTRESK by pharmacological agents
In order to validate our modeling study, we tested the afﬁnity of
F156 and F364 for mTRESK channels expressed in HEK-293A cells in
respond to TRESK blockers. Phenylalanine residues of mTRESK were
mutated to alanine (F156A, F364A, and F156A/F364A) at the TM2 and
TM4, and each mutant was expressed in HEK-293A cells. In physiologi-
cal bath solution containing 5 mMKCl, the membrane potential of cells
under the whole-cell conﬁguration was held at −80 mV, and then a
ramp pulse (−120 to +60 mV; 1-s duration) was applied. In control
cells transfected with plasmid containing GFP alone, the ramp pulse
elicited very small currents (b0.2 nA at +60 mV; n=6). However, in
cells transfected with TRESK/GFP DNA, the same ramp pulse produced
large currents (b10 nA at +60 mV; n=6; Fig. 8) with reversal poten-
tials near -80 mV, indicating that wild-type (WT) and mutant mTRESK
formed a functional K+ channel in the plasma membrane of HEK-293
cells. All of the mutants expressed functional currents in transfected
cells, as judged by measurement of single-channel and whole-cell
current (Fig. 8A). The single-channel was observed before recording
whole-cell currents (upper left hand side in Fig. 8A). WT and mutant
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Fig. 8.Modulation of mTRESK mutants by TRESK blockers. (A) Potential binding sites were mutated to prevent binding of blockers to TRESK transmembrane domains, and the mu-
tants were expressed in HEK-293A cells. Whole cell currents were recorded using the ramp pulse protocol before and after application of bupivacaine, lidocaine, and quinine. The
cell membrane potential was held at−80 mV, and then a voltage ramp (−120 to +60 mV; 1-s duration) was implemented out at room temperature. Con, Bupi, and Lido indicate
control, bupivacaine, and lidocaine, respectively. The single-channels shown in upper left hand side were recorded before forming whole-cell conﬁguration in physiological solu-
tion. (B) Summary of the effects of bupivacaine, lidocaine, and quinine on TRESK channel activity in whole-cell mode. Bar graphs show % inhibition of TRESK currents produced by
blockers for mutants at +60 mV. Each bar represents means±S.D. of six independent experiments. *pb0.05 and #pb0.05 indicate signiﬁcant difference from the value observed
with wild-type and F364A mutant, respectively.
1139S. Kim et al. / Biochimica et Biophysica Acta 1828 (2013) 1131–1142different amount of mTRESK currents. These results suggest that each
cell may control transcription and translation levels differently. Under
whole-cell conditions, extracellular application of 100 μM bupivacaine,
1 mM lidocaine, and 100 μM quinine decreased WT currents by 82±4%, 83±5%, and 82±8%, respectively. F156A and F364A mutants are
less sensitive to quinine, lidocaine, and bupivacaine compared with
WT. In F156A and F364A mutants, bupivacaine, lidocaine, and quinine
inhibited the currents by 70±10% and 58±10%, 78±12% and 40±
1140 S. Kim et al. / Biochimica et Biophysica Acta 1828 (2013) 1131–114212%, and 76±8% and 38±9%, respectively. The mTRESK currents gen-
erated by thesemutants were similar to those generated byWT (Fig. 8).
To test the importance of phenylalanine at the two amino acid res-
idues (F156 and F364), a double mutant was constructed and tested
for sensitivity to quinine, lidocaine, and bupivacaine. F156A/F364A dou-
ble mutant was insensitive to the blockers. Bupivacaine, lidocaine, and
quinine slightly inhibited the currents of F156A/F364A mutant by
15±14%, 20±15%, and 18±11%, respectively. The % of inhibition by
blockers was signiﬁcantly small compared with that in WT currents
(pb0.05, Fig. 8A and B). Also the amounts reduced by blockers in
F156A/F364A current were also signiﬁcantly lower than those in
F364A current (Fig. 8B).
Additional computational study was carried out to investigate the
binding mode difference between the mutants and WT. Three com-
pounds such as bupivacaine, lidocaine, and quinine which were used
in experimental study were docked into each mutant structure. In
comparison of the mutants with WT, each ﬁtness score for the
compounds with mutants was slightly lower than for those with WT.
As shown in Table S1, the ﬁtness scores are not showing deﬁnite
correlation with measured current inhibition for the blockers. In this
study, the ﬁtness scoreswere used to ﬁnd out the proper ligand binding
positionwith key interacting residues rather than to ﬁndout quite exact
correlation with binding afﬁnities because the ﬁtness score has been
optimized for the prediction of ligand binding positions [56]. In binding
mode analysis, we found that while the single mutants (F156A or
F364A) showed π interactions with aromatic ring group of the com-
pounds, the doublemutant (F156A/F364A) had no corresponding inter-
actions (Fig. S5). Thus, these results are consistent with experimental
study, showing low current in double mutants.
To identifywhether non-blockers of TRESK also affect F156 and F364
sites of TRESK, 9-anthracene carboxylic acid (9-AC), a chloride channel
blocker, and tetraethylammonium (TEA), a K+ channel blocker but not
TRESK, were applied to WT and mutant TRESK currents overexpressed
in HEK-293A cells. As shown in Fig. 9, the 9-AC did not inhibit TRESK
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Fig. 9. Effect of 9-AC and TEA on TRESK mutants. (A) No signiﬁcant effect of 9-AC and TE
chemicals treated (9-AC and TEA). Black and gray lines indicate control and treatment, re
whole-cell mode. Bar graphs show % changes of TRESK currents produced by 9-AC and TEA a
ative indicates inhibition.TEA slightly inhibited TRESK currents. The inhibition amounts by TEA
were 4±8%, 4±7%, 2±8%, and 9±4% in WT, F156A, F364A, F156A/
F364A, respectively. The effects of 9-AC and TEA on TRESK mutants
were similar to those on TRESK WT. In docking result of the TEA,
completely different binding mode with other blockers showing the
lowest ﬁtness scores of 24.90, 29.23, 22.33, and 27.88 for WT, F156A,
F364A, and F156A/F364A, respectively (Table S1). This computational
result indicates that non-blocker of TRESK cannot bind properly with
cavity region of the protein. These results suggest that each non-blocker
might have a different binding site for each protein channel.
4. Conclusions
The aims of this study were to obtain reasonable 3D structure
and to ﬁnd out the proper binding site of K+ channel blockers. The
3D structure was built by homology modeling with considering
the TM topology of mTRESK obtained from TMHMM prediction.
The minimized ﬁnal structures were achieved for subsequent molec-
ular docking and MD simulations. In pore radius analysis, similar
pore radius of selectivity ﬁlter was observed in mTRESK compared
with template structure, whereas pore dimension of gate region
was narrower than that of the template. This narrow dimension
was caused by four phenylalanine residues consisting of F156 and
F364 located in each monomer. The representative structure of the
ligand-adjusted protein conformation was obtained from molecular
docking and 5 ns MD simulation with DPPC lipid bilayer. The confor-
mation was used for ﬁnal molecular docking for the blockers. From
our docking study, the plausible binding mode of known K+ channel
blockers was investigated into the mTRESK internal binding site, and
key interacting residues were identiﬁed. Especially, two phenylala-
nine residues, F156 and F364, were considered as critical key resi-
dues for blocker binding. This prediction was tested by mutations
of F156A, F364A, and F156A/F364A, and the results support the im-
portance of these residues. Based on these results we can conclude
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A on currents produced from WT and mutants. Same experiment as in Fig. 8 except
spectively. (B) Summary of the effects of 9-AC and TEA on TRESK channel activity in
t +60 mV. Each bar represents means±S.D. of six independent experiments. The neg-
1141S. Kim et al. / Biochimica et Biophysica Acta 1828 (2013) 1131–1142for ﬁnding the bindingmode properly. Our study is ﬁrst modeling study
of TRESK to provide structural knowledge including ligand binding
information. Furthermore, this would be helpful to structure-based
drugs design for TRESK as a potential therapeutic target in the reduc-
ing of pain.
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